|
Título:
|
Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru
|
|
Autores:
|
Otero, L. ;
De Orbegoso, A. ;
Navarro, A. F. ;
Rìos, J. ;
Parraga, T. ;
Gotuzzo, E. ;
Seas, C. ;
Van der Stuyft, P.
|
|
Tipo de documento:
|
texto impreso
|
|
Editorial:
|
Wiley, 2019-02-06T14:57:42Z
|
|
Nota general:
|
info:eu-repo/semantics/restrictedAccess
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
|
|
Idiomas:
|
Inglés
|
|
Palabras clave:
|
Editados por otras instituciones
,
Artículos
,
Artículos en revistas indizadas
|
|
Resumen:
|
OBJECTIVE: To determine the time from diagnosis to start of multidrug resistant tuberculosis (MDR TB) treatment in Lima, Peru. METHODS: We studied new smear-positive TB adults that were started on MDR TB treatment or that were switched to it between June 2008 and December 2011. RESULTS: Time from the first positive smear to MDR-TB treatment was >30 days in 35% (13/37) of patients. Among the 27% (24/88) of patients that switched to MDR-TB treatment, time from the last dose of a drug-susceptible regimen was >30 days. CONCLUSION: Start of and switching to MDR TB treatment is still delayed.
|
|
En línea:
|
http://doi.org/10.1111/tmi.12430
|
